LGP have complete supply chain control from cultivating, testing, processing, distribution and retail/patient, as well as R&D operations, clinical trials, genetic programs and the like.
To compare or call them just a 'cultivator' sort of undermines and undervalues the offering they have. They are already good to go with GMP certification which is going to kick in as mandatory later in the year while a lot of other companies will be chasing their tails trying to get certified or working a way around it.
The edge they have is that they don't have to rely on any external parties in order to bring their products to market, which might be an issue for some as the GMP cert hits, and suddenly "Australian" importers have to invest in making sure they comply which will probably see an increase in overheads in the 'frugal' companies.
LGP Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)